2023 Q4 Form 10-Q Financial Statement

#000149315223041197 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $2.830M $2.156M $726.0K
YoY Change 11.86% 196.97% 2241.94%
Cost Of Revenue $1.567M $780.0K $877.0K
YoY Change -29.41% -11.06%
Gross Profit $1.263M $1.376M -$151.0K
YoY Change 307.42% -1011.26% -587.1%
Gross Profit Margin 44.63% 63.82% -20.8%
Selling, General & Admin $2.019M $2.239M $1.474M
YoY Change -5.65% 51.9% -7.59%
% of Gross Profit 159.86% 162.72%
Research & Development $163.0K $242.0K $350.0K
YoY Change -70.36% -30.86% -24.24%
% of Gross Profit 12.91% 17.59%
Depreciation & Amortization $76.00K $86.00K $40.00K
YoY Change 8.57% 115.0% 300.0%
% of Gross Profit 6.02% 6.25%
Operating Expenses $2.182M $2.481M $1.824M
YoY Change -18.88% 36.02% -11.33%
Operating Profit -$919.0K -$1.105M -$1.975M
YoY Change -61.39% -44.05% -2.52%
Interest Expense $154.0K $13.00K -$50.00K
YoY Change -485.0% -126.0% -350.0%
% of Operating Profit
Other Income/Expense, Net $22.00K -$51.00K
YoY Change -143.14% -383.33%
Pretax Income -$1.436M -$1.092M -$2.026M
YoY Change -40.66% -46.1% 0.8%
Income Tax -$133.0K $40.00K
% Of Pretax Income
Net Earnings -$1.303M -$1.132M -$2.026M
YoY Change -45.25% -44.13% 0.9%
Net Earnings / Revenue -46.04% -52.5% -279.06%
Basic Earnings Per Share -$0.44 -$0.08
Diluted Earnings Per Share -$3.20 -$0.44 -$2.00
COMMON SHARES
Basic Shares Outstanding 2.982M shares 2.439M shares 25.55M shares
Diluted Shares Outstanding 2.559M shares 1.026M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.187M $3.695M $4.360M
YoY Change 1.86% -15.25% 23.16%
Cash & Equivalents $2.187M $3.695M $4.360M
Short-Term Investments $6.000K
Other Short-Term Assets $99.00K $72.00K $260.0K
YoY Change -61.92% -72.31% -3.7%
Inventory $2.879M $2.395M $1.059M
Prepaid Expenses $65.00K
Receivables $615.0K $690.0K $386.0K
Other Receivables $847.0K $1.218M $650.0K
Total Short-Term Assets $6.627M $8.070M $6.718M
YoY Change 9.39% 20.13% 69.22%
LONG-TERM ASSETS
Property, Plant & Equipment $472.0K $112.0K $144.0K
YoY Change 237.14% -22.22% -84.0%
Goodwill $758.0K $1.401M $268.0K
YoY Change -45.66% 422.76%
Intangibles $1.097M $1.149M $294.0K
YoY Change -20.33% 290.82%
Long-Term Investments $30.00K $73.00K $80.00K
YoY Change -80.0% -8.75% -27.27%
Other Assets $7.000K $26.00K $30.00K
YoY Change -76.67% -13.33%
Total Long-Term Assets $2.364M $3.133M $1.473M
YoY Change -35.57% 112.7% 47.3%
TOTAL ASSETS
Total Short-Term Assets $6.627M $8.070M $6.718M
Total Long-Term Assets $2.364M $3.133M $1.473M
Total Assets $8.991M $11.20M $8.191M
YoY Change -7.57% 36.77% 64.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.154M $2.617M $1.350M
YoY Change -13.49% 93.85% 7.14%
Accrued Expenses $158.0K $137.0K $180.0K
YoY Change -1.25% -23.89% 38.46%
Deferred Revenue
YoY Change
Short-Term Debt $158.0K $230.0K $200.0K
YoY Change 1.94% 15.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.878M $4.573M $2.135M
YoY Change -7.2% 114.19% 53.6%
LONG-TERM LIABILITIES
Long-Term Debt $249.0K $268.0K $86.00K
YoY Change -33.78% 211.63%
Other Long-Term Liabilities $129.0K $156.0K $370.0K
YoY Change -58.39% -57.84% -24.49%
Total Long-Term Liabilities $378.0K $698.0K $522.0K
YoY Change -62.65% 33.72% 6.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.878M $4.573M $2.135M
Total Long-Term Liabilities $378.0K $698.0K $522.0K
Total Liabilities $4.256M $5.271M $2.657M
YoY Change -18.01% 98.38% 41.33%
SHAREHOLDERS EQUITY
Retained Earnings -$59.88M -$58.58M -$51.12M
YoY Change 11.93% 14.59%
Common Stock $4.000K $3.000K $26.00K
YoY Change 300.0% -88.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.735M $5.932M $5.534M
YoY Change
Total Liabilities & Shareholders Equity $8.991M $11.20M $8.191M
YoY Change -7.57% 36.77% 64.81%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$1.303M -$1.132M -$2.026M
YoY Change -45.25% -44.13% 0.9%
Depreciation, Depletion And Amortization $76.00K $86.00K $40.00K
YoY Change 8.57% 115.0% 300.0%
Cash From Operating Activities -$1.196M -$1.270M -$1.790M
YoY Change -16.36% -29.05% 36.64%
INVESTING ACTIVITIES
Capital Expenditures $7.000K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$7.000K $0.00 $0.00
YoY Change -98.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -96.00K 3.634M -20.00K
YoY Change 220.0% -18270.0% -166.67%
NET CHANGE
Cash From Operating Activities -1.196M -1.270M -1.790M
Cash From Investing Activities -7.000K 0.000 0.000
Cash From Financing Activities -96.00K 3.634M -20.00K
Net Change In Cash -1.299M 2.364M -1.810M
YoY Change -38.73% -230.61% 41.41%
FREE CASH FLOW
Cash From Operating Activities -$1.196M -$1.270M -$1.790M
Capital Expenditures $7.000K $0.00 $0.00
Free Cash Flow -$1.203M -$1.270M -$1.790M
YoY Change -15.87% -29.05% 36.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001211805
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 MYSZ Equity Loss Of Equity Method Investees
EquityLossOfEquityMethodInvestees
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
MYSZ Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
usd
CY2023Q3 MYSZ Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
usd
CY2023Q3 MYSZ Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
usd
CY2022Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
CY2022Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
MYSZ Change In Warrants And Derivatives
ChangeInWarrantsAndDerivatives
usd
MYSZ Increase Decrease In Investment In Joint Venture
IncreaseDecreaseInInvestmentInJointVenture
usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
MYSZ Noncash Or Part Noncash Acquisition Issuance Of Shares
NoncashOrPartNoncashAcquisitionIssuanceOfShares
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37370
dei Entity Registrant Name
EntityRegistrantName
MY SIZE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
51-0394637
dei Entity Address Address Line1
EntityAddressAddressLine1
HaYarden 4
dei Entity Address Address Line2
EntityAddressAddressLine2
POB 1026
dei Entity Address City Or Town
EntityAddressCityOrTown
Airport City
dei Entity Address Country
EntityAddressCountry
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
7010000
dei City Area Code
CityAreaCode
972
dei Local Phone Number
LocalPhoneNumber
3-600-9030
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
MYSZ
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2981792 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3695000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2100000 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
72000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
263000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2395000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
997000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
690000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1940000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1218000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
758000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
8070000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
6058000 usd
CY2023Q3 us-gaap Deposit Assets
DepositAssets
26000 usd
CY2022Q4 us-gaap Deposit Assets
DepositAssets
28000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
112000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
140000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
372000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
583000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1149000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1377000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1401000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
1395000 usd
CY2023Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
47000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
99000 usd
CY2023Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
26000 usd
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
47000 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
3133000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3669000 usd
CY2023Q3 us-gaap Assets
Assets
11203000 usd
CY2022Q4 us-gaap Assets
Assets
9727000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
137000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
159000 usd
CY2023Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
230000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
155000 usd
CY2023Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2617000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2487000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
734000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
698000 usd
CY2023Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
855000 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
680000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4573000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4179000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
268000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
376000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
274000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
328000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
156000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
308000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
698000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1012000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
5271000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5191000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2981792 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2981792 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1464117 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1464117 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
65219000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
58673000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-712000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-637000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58578000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53501000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5932000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4536000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11203000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9727000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4166000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1931000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2156000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
726000 usd
us-gaap Cost Of Revenue
CostOfRevenue
2698000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
877000 usd
us-gaap Cost Of Revenue
CostOfRevenue
2698000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1607000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
780000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
877000 usd
us-gaap Gross Profit
GrossProfit
1468000 usd
us-gaap Gross Profit
GrossProfit
324000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1376000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
-151000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
811000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1152000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
242000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
350000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2598000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2526000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
952000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
672000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3210000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2378000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1287000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
802000 usd
us-gaap Operating Expenses
OperatingExpenses
6619000 usd
us-gaap Operating Expenses
OperatingExpenses
6056000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
2481000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1824000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5151000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5732000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1105000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1975000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-78000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-198000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-51000 usd
MYSZ Equity Loss Of Equity Method Investees
EquityLossOfEquityMethodInvestees
48000 usd
CY2023Q3 MYSZ Equity Loss Of Equity Method Investees
EquityLossOfEquityMethodInvestees
9000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5277000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5930000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1092000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2026000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5077000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5930000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1132000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2026000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-75000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-178000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-36000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-300000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5152000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6108000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1168000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2326000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2559371 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2559371 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1025564 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1025564 shares
us-gaap Inventory Write Down
InventoryWriteDown
643000 usd
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:25 reverse stock split
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4536000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
290000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
959000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6258000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6258000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5152000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5932000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10857000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
327000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
458000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6108000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5534000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3433000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
68000 usd
CY2023Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
518000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3599000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3599000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1168000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5932000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7695000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7695000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
165000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2326000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5534000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5534000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5077000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5930000 usd
us-gaap Depreciation
Depreciation
27000 usd
us-gaap Depreciation
Depreciation
32000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
130000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
30000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
226000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
84000 usd
MYSZ Change In Warrants And Derivatives
ChangeInWarrantsAndDerivatives
26000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
36000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
32000 usd
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
16000 usd
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
3000 usd
us-gaap Interest Paid
InterestPaid
16000 usd
us-gaap Interest Paid
InterestPaid
3000 usd
MYSZ Revaluation Of Investment In Marketable Securities
RevaluationOfInvestmentInMarketableSecurities
-21000 usd
MYSZ Revaluation Of Investment In Marketable Securities
RevaluationOfInvestmentInMarketableSecurities
-28000 usd
MYSZ Increase Decrease In Investment In Joint Venture
IncreaseDecreaseInInvestmentInJointVenture
52000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
290000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
327000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1530000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
288000 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-328000 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-19000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1165000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
281000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-101000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
351000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-140000 usd
MYSZ Increase Decrease In Trade Payable
IncreaseDecreaseInTradePayable
271000 usd
MYSZ Increase Decrease In Trade Payable
IncreaseDecreaseInTradePayable
-503000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
259000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
464000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4910000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5858000 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
300000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-327000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6257000 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
350000 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
18000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
377000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
57000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6230000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-39000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
84000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-97000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1404000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6321000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2363000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10943000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3767000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4622000 usd
MYSZ Noncash Or Part Noncash Acquisition Issuance Of Shares
NoncashOrPartNoncashAcquisitionIssuanceOfShares
457000 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1213000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
191000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58578000 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
21000 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
11000 usd
CY2023Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
7000 usd
CY2022Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
22000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
290000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
327000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
68000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
165000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
8000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1401000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
268000 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.805
CY2023Q3 MYSZ Incremental Compensation Cost
IncrementalCompensationCost
10000 usd
CY2023Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4200000 usd
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
mysz-20230930_pre.xml Edgar Link unprocessable
mysz-20230930_lab.xml Edgar Link unprocessable
mysz-20230930_cal.xml Edgar Link unprocessable
mysz-20230930_def.xml Edgar Link unprocessable
0001493152-23-041197-index-headers.html Edgar Link pending
0001493152-23-041197-index.html Edgar Link pending
0001493152-23-041197.txt Edgar Link pending
0001493152-23-041197-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
mysz-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending